The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); ArQule (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Cleave Biosciences (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Genmab (Inst); Halozyme (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Meryx Pharmaceuticals (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Rgenix (Inst); Sanofi (Inst); Syndax (Inst)

How will the cost of biosimilars affect patients’ willingness to receive them?
 
R Donald Harvey
No Relationships to Disclose
 
Megan McGrath
No Relationships to Disclose
 
John W. Cook
No Relationships to Disclose
 
Margie D Dixon
No Relationships to Disclose
 
Rebecca D. Pentz
No Relationships to Disclose